March 25, 2011
ORLANDO, Fla. - At the 17th annual Society for Biomolecular Sciences 2011 conference in Orlando, Florida, PerkinElmer, Inc., a global leader focused on the health and safety of people and the environment, will be showcasing several new drug discovery technologies and applications. The PerkinElmer exhibit, located at Booth 701, will include new products based on [...]
Biognosys and ETH Zurich Publish Software in Nature Methods for High Throughput MRM
March 25, 2011
The growing field of targeted proteomics has reached another milestone on the way to large-scale application in industrial and academic research, following the publication in Nature Methods of a new tool designed to make the latest developments in the field more accessible. The advancement is mProphet, a software package created by scientists from the Institute [...]
Showa Denko K.K. and Shoko to Strengthen Scientific Instrument Business
March 25, 2011
Tokyo - IR & PR Office (Phone: 81-3-5470-3235) (SDK) and its consolidated subsidiary Shoko Co., Ltd. (Shoko) have decided to integrate their businesses in high-performance liquid chromatography* (HPLC). HPLC is used for analyzing molecular weight of polymers, chemical substances in food, pharmaceuticals, and agrochemicals, as well as quality of water. The integration is scheduled to [...]
March 24, 2011
RUSNANO has invested $4.5 million dollars in a project to expand production of label-free biodetectors and bionanoslides with their American developer, BiOptix Diagnostics, Inc. Two American venture capital funds, Boulder Ventures, Ltd. and Peierls Foundation, and private investors have invested another $4.5 million in authorized capital of BiOptix. The project, which has a total budget [...]
Visualsonics Launches Revolutionary Imaging Technology To Advance Cancer Research
March 24, 2011
TORONTO, Canada - VisualSonics Inc., a leader in real time, in vivo, high-resolution micro-imaging systems and a wholly-owned subsidiary of SonoSite Inc., (Nasdaq:Sono), today announced the launch of the Vevo® LAZR Photoacoustics Imaging system for the advancement of cancer research in the pre-clinical imaging market. This revolutionary technology combines the sensitivity of optical imaging with [...]
LABVANTAGE Launches 24/7 Technical Support to Assure Organizations’ Business Continuity
March 24, 2011
Bridgewater, NJ. - LABVANTAGE today announced the opening of its 24/7 Technical Support center. The center provides LABVANTAGE’s customers continuous, live telephone support 24 hours a day, 7 days a week and 365 days a year. “LABVANTAGE has always been dedicated to resolving product issues in a timely and effective manner for our customers,” states [...]
March 24, 2011
TORONTO - The Ontario Institute for Cancer Research (OICR) announced today it has made an investment to accelerate commercialization of a potentially revolutionary high-throughput screening technology directed at the discovery of anticancer drugs. The technology, Smart Well Plate™, developed at the University of Toronto, is a palm-sized device that utilizes digital microfluidics (DMF), a technique [...]
Biotage Introduces Unique, Entry-Level System for Microwave-Assisted Peptide Synthesis
March 24, 2011
Uppsala, Sweden - Biotage® (STO: BIOT), a leading supplier of tools and technology for medicinal, analytical and peptide chemistry, introduced the Biotage Initiator Peptide Workstation for manual microwave-assisted peptide synthesis. The Workstation utilizes a unique microwave peptide vial available in two sizes; 2-5 mL for 75-150 ?mol scale or 10-20 mL for 250-500 ?mol scale [...]
Agilent Technologies Expands Life Sciences and Chemical Analysis Center of Excellence in India
March 24, 2011
BANGALORE, India - Agilent Technologies Inc. (NYSE: A) has expanded its Life Sciences and Chemical Analysis Center of Excellence in Bangalore. The company also has opened a Life Science application development lab, in an adjacent facility, to accelerate the discovery of life science analysis workflows. Together, the center and lab cover 8,000 square feet, making [...]
ChanTest Corporation and Molecular Devices, Inc. Sign Cell Line Distribution Agreement
March 24, 2011
CLEVELAND & SUNNYVALE, Calif. - Molecular Devices, Inc. and ChanTest Corporation, leading providers of ion channel and GPCR drug discovery tools and solutions, have signed an agreement for Molecular Devices to distribute ChanTest’s extensive portfolio of ion channel and GPCR cell lines on a non-exclusive basis. As part of the agreement, Molecular Devices, Inc. will [...]
